| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.008 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.008 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.009 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.18 | 0.009 |